Last update June 15, 2022
Compatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
لوراسيدون is Lurasidone in Arabic.
Is written in other languages:لوراسيدون belongs to these groups or families:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Atypical or second generation antipsychotic used in the treatment of schizophrenia and the depressive phase of bipolar disorder. Oral administration once daily.
It is excreted in breast milk in a clinically insignificant amount and no problems were observed in one infant whose mother was taking it. Plasma levels in that infant were very low. (Keightley 2020)
Its pharmacokinetic data (very high percentage of protein binding, very large volume of distribution and moderately high molecular weight) explain the negligible passage into breast milk observed.
Lurasidone has little or no significant effect on prolactin levels. (Peuskens 2014)
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable, especially during the neonatal period and in the event of prematurity.
See below the information of this related product: